By JCN Newswire | Article Rating: |
|
May 27, 2014 02:14 AM EDT | Reads: |
506 |
Contains 5 Ingredients that Help Bring Out the Beauty From Within & Sodium Supplement
Tokyo, May 27, 2014 - (JCN Newswire) - Eisai Co., Ltd. (Headquarters: Tokyo, President & CEO: Haruo Naito, "Eisai") announced today that it will launch its new carbonated supplement drink Chocola BB Sparkling Salty Natsumikan* Flavor, classified as a Food with Nutrient Function Claims, in Japan on Monday, June 2.
Chocola BB Sparkling Salty Natsumikan Flavor is a new carbonated supplement drink classified by the Japanese Ministry of Health, Labour and Welfare as a Food with Nutrient Function Claims (Niacin). The drink contains five ingredients that help bring out women's beauty from within, including 1,500 mg of vitamin C in addition to niacin, vitamin B1, B6 and iron, and it also contains 56 mg of sodium which becomes increasingly vital for sodium replenishment during summer. It features the clean and refreshing taste of natsumikan, which is popular as a fruit with the image of summer, as well as a low calorie count of just 24 kcal per bottle. As a delicious and easy way to replenish sodium, the drink is designed to address the needs of women who want to stay energetic all summer long.
Chocola BB Sparkling Salty Natsumikan Flavor is the newest member of the Chocola BB Sparkling series including Chocola BB Sparkling Grapefruit & Peach Flavor, Chocola BB Sparkling White Grape Flavor and Chocola BB Sparkling Vitamin Kyutto Lemon Flavor, all of which have been well-received since launch.
Eisai will continue to provide the Chocola BB family of products to respond to the diverse needs of female consumers and support an ever-growing number of people to achieve health and beauty in their everyday lives.
Note:
*Natsumikan: A yellowish orange citrus fruit native to Japan
About Eisai
Eisai Co., Ltd. (TSE: 4523; ADR: ESALY) is a research-based human health care (hhc) company that discovers, develops and markets products throughout the world. Eisai focuses its efforts in three therapeutic areas: integrative neuroscience, including neurology and psychiatric medicines; integrative oncology, which encompasses oncotherapy and supportive-care treatments; and vascular/immunological reaction. Through a global network of research facilities, manufacturing sites and marketing subsidiaries, Eisai actively participates in all aspects of the worldwide healthcare system. For more information about Eisai Co., Ltd., please visit www.eisai.com.
Source: Eisai
Contact:
Copyright 2014 JCN Newswire. All rights reserved. www.japancorp.net
Tokyo, May 27, 2014 - (JCN Newswire) - Eisai Co., Ltd. (Headquarters: Tokyo, President & CEO: Haruo Naito, "Eisai") announced today that it will launch its new carbonated supplement drink Chocola BB Sparkling Salty Natsumikan* Flavor, classified as a Food with Nutrient Function Claims, in Japan on Monday, June 2.
Chocola BB Sparkling Salty Natsumikan Flavor is a new carbonated supplement drink classified by the Japanese Ministry of Health, Labour and Welfare as a Food with Nutrient Function Claims (Niacin). The drink contains five ingredients that help bring out women's beauty from within, including 1,500 mg of vitamin C in addition to niacin, vitamin B1, B6 and iron, and it also contains 56 mg of sodium which becomes increasingly vital for sodium replenishment during summer. It features the clean and refreshing taste of natsumikan, which is popular as a fruit with the image of summer, as well as a low calorie count of just 24 kcal per bottle. As a delicious and easy way to replenish sodium, the drink is designed to address the needs of women who want to stay energetic all summer long.
Chocola BB Sparkling Salty Natsumikan Flavor is the newest member of the Chocola BB Sparkling series including Chocola BB Sparkling Grapefruit & Peach Flavor, Chocola BB Sparkling White Grape Flavor and Chocola BB Sparkling Vitamin Kyutto Lemon Flavor, all of which have been well-received since launch.
Eisai will continue to provide the Chocola BB family of products to respond to the diverse needs of female consumers and support an ever-growing number of people to achieve health and beauty in their everyday lives.
Note:
About Eisai
Eisai Co., Ltd. (TSE: 4523; ADR: ESALY) is a research-based human health care (hhc) company that discovers, develops and markets products throughout the world. Eisai focuses its efforts in three therapeutic areas: integrative neuroscience, including neurology and psychiatric medicines; integrative oncology, which encompasses oncotherapy and supportive-care treatments; and vascular/immunological reaction. Through a global network of research facilities, manufacturing sites and marketing subsidiaries, Eisai actively participates in all aspects of the worldwide healthcare system. For more information about Eisai Co., Ltd., please visit www.eisai.com.
Source: Eisai
Contact:
Public Relations Department, Eisai Co., Ltd. +81-3-3817-5120
Copyright 2014 JCN Newswire. All rights reserved. www.japancorp.net
Published May 27, 2014 Reads 506
Copyright © 2014 SYS-CON Media, Inc. — All Rights Reserved.
Syndicated stories and blog feeds, all rights reserved by the author.
More Stories By JCN Newswire
Copyright 2008 JCN Newswire. All rights reserved. Republication or redistribution of JCN Newswire content is expressly prohibited without the prior written consent of JCN Newswire. JCN Newswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
Latest Stories
Apr. 23, 2018 09:30 AM EDT Reads: 2,156 |
By Yeshim Deniz Apr. 23, 2018 09:30 AM EDT Reads: 3,227 |
By Pat Romanski Apr. 23, 2018 09:30 AM EDT Reads: 2,290 |
By Elizabeth White ![]() Apr. 23, 2018 09:15 AM EDT Reads: 6,509 |
By Yeshim Deniz Apr. 23, 2018 09:15 AM EDT Reads: 1,651 |
By Liz McMillan Apr. 23, 2018 09:15 AM EDT Reads: 2,654 |
By Yeshim Deniz Apr. 23, 2018 09:00 AM EDT Reads: 2,789 |
By Yeshim Deniz Apr. 23, 2018 09:00 AM EDT Reads: 3,165 |
By Yeshim Deniz Apr. 23, 2018 08:45 AM EDT Reads: 2,625 |
By Liz McMillan ![]() Apr. 23, 2018 08:00 AM EDT Reads: 1,469 |
By Liz McMillan ![]() Apr. 23, 2018 08:00 AM EDT Reads: 2,127 |
By Liz McMillan ![]() Apr. 23, 2018 07:45 AM EDT Reads: 5,588 |
By Elizabeth White ![]() Apr. 23, 2018 07:15 AM EDT Reads: 1,113 |
By Yeshim Deniz Apr. 23, 2018 07:15 AM EDT Reads: 1,090 |
By Liz McMillan ![]() Apr. 23, 2018 07:15 AM EDT Reads: 3,758 |